NATCO PHARMA LTD. |
End-of-day quote
Other stock markets
|
||
| - INR | - |
|
| 05-28 | INDIA STOCKS-Metal, pharma stocks drive Indian benchmarks higher | RE |
| 05-28 | Transcript : NATCO Pharma Limited, Q4 2024 Earnings Call, May 28, 2024 |
Chart calendar Natco Pharma Ltd.
f26dff32.h3TlXKiECo5AF-xI9B7Kq1ct5VisCsCOV7MSeXZAyGc.7xCracnVTvoUQZlwwluphgFXrW72PJrAZOlnOz4EvheyB5Qkxu5bti9ugw~c6579483ceb4c219e0e705e1276bb41a
Upcoming events on Natco Pharma Ltd.
Past events on Natco Pharma Ltd.
| 2024-07-04 00:30 | Investor Meeting - ICICI Securities |
| 2024-06-10 06:00 | Investor Meeting - J M Financial |
| 2024-05-29 | B&K Securities Trinity Investor Conference |
| 2024-05-29 01:30 | Investor Meeting - ICICI Securities |
| 2024-05-28 01:30 | Q4 2024 Earnings Call |
| 2024-05-27 07:12 | Q4 2024 Earnings Release |
| 2024-04-22 02:30 | Investor Meeting - HSBC Global |
| 2024-03-06 01:30 | Investor Meeting - ICICI Securities |
| 2024-02-27 22:30 | Investec Promoter & Founder Conference |
| 2024-02-15 00:30 | Q3 2024 Earnings Call |
| 2024-02-14 03:38 | Q3 2024 Earnings Release |
| 2023-12-15 01:00 | Investor Meeting - Kotak PCG |
| 2023-11-28 22:30 | Investor Meeting |
| 2023-11-27 22:30 | Investor Meeting - Day 1 |
| 2023-11-15 00:30 | Q2 2024 Earnings Call |
| 2023-11-14 03:44 | Q2 2024 Earnings Release |
| 2023-09-29 01:00 | Annual General Meeting |
| 2023-08-10 01:30 | Q1 2024 Earnings Call |
| 2023-08-09 05:20 | Q1 2024 Earnings Release |
| 2023-05-30 01:30 | Q4 2023 Earnings Call |
Annual results
| Fiscal Period | Marzo | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 20 945 22 060 -5.05% | 19 150 19 446 -1.52% | 20 521 21 294 -3.63% | 19 448 19 848 -2.02% | 27 071 26 844 0.85% | 39 988 39 185 2.05% |
|
EBITDA Million INR | Released Forecast Spread | 7 948 9 009 -11.77% | 5 826 6 531 -10.79% | 6 062 6 289 -3.61% | 2 635 5 360 -50.84% | 9 356 9 761 -4.15% | 17 514 16 899 3.64% |
|
EBIT Million INR | Released Forecast Spread | 7 138 8 815 -19.03% | 4 828 5 211 -7.35% | 4 893 5 247 -6.75% | 1 209 4 105 -70.55% | 7 718 8 088 -4.57% | 15 646 15 221 2.79% |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 8 247 8 947 -7.83% | 5 687 6 043 -5.88% | 5 796 6 107 -5.09% | 2 022 5 124 -60.54% | 8 619 9 068 -4.96% | 16 735 16 001 4.59% |
|
Net income Million INR | Released Forecast Spread | 6 444 6 969 -7.54% | 4 608 4 832 -4.64% | 4 409 4 739 -6.95% | 1 700 3 978 -57.26% | 7 153 7 188 -0.49% | 13 883 13 212 5.08% |
|
EPS INR | Released Forecast Spread | 34,9 37,8 -7.75% | 25,3 28,1 -10.08% | 24,2 26,0 -7.15% | 9,32 21,9 -57.44% | 39,2 39,5 -0.77% | 77,3 73,2 5.61% |
| Announcement Date | 27/05/19 | 17/06/20 | 17/06/21 | 30/05/22 | 29/05/23 | 27/05/24 |
Quarterly results
| Fiscal Period | Marzo | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 3 313 4 556 -27.29% | 4 103 4 479 -8.4% | 3 772 4 390 -14.08% | 5 605 4 620 21.31% | 5 968 5 662 5.4% | 8 846 8 159 8.42% | 4 321 6 309 -31.51% | 4 925 5 421 -9.14% | 8 979 8 321 7.91% | 11 405 11 402 0.02% | 10 790 | 5 742 | 9 922 | 13 834 |
|
EBITDA Million INR | Released Forecast Spread | 762 1 268 -39.91% | 1 098 1 179 -6.84% | 705 1 134 -37.82% | 1 018 1 145 -11.05% | -186 2 002 -109.29% | 3 953 3 662 7.93% | 953 2 034 -53.14% | 1 059 1 322 -19.91% | 3 391 3 606 -5.95% | 5 280 5 247 0.63% | 4 930 | 1 284 | 4 376 | 7 325 |
|
EBIT Million INR | Released Forecast Spread | 692 | 3 504 | 9 664 | |||||||||||
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 910 853 6.68% | 698 1 067 -34.58% | 910 1 144 -20.45% | -496 1 323 -137.49% | 3 858 2 889 33.54% | 814 833 -2.28% | 3 244 1 583 104.93% | 5 000 4 273 17.01% | 4 672 | 4 732 | 7 960 | |||
|
Net income Million INR | Released Forecast Spread | 530 1 027 -48.39% | 750 779 -3.69% | 651 775 -15.96% | 804 862 -6.69% | -505 1 368 -136.92% | 3 204 2 192 46.17% | 568 1 385 -59% | 623 942 -33.87% | 2 758 2 596 6.22% | 4 203 3 957 6.22% | 5 355 | 833 | 3 241 | 6 204 |
|
EPS INR | Released Forecast Spread | 4,11 4,35 -5.52% | 3,57 4,80 -25.63% | 4,40 4,60 -4.35% | -2,77 7,30 -137.95% | 17,6 12,4 41.53% | 3,11 5,10 -39.02% | 3,41 3,90 -12.56% | 15,1 6,80 122.21% | 23,3 19,0 22.42% | 21,4 | 3,68 | 15,0 | 41,3 | |
| Announcement Date | 17/06/21 | 12/08/21 | 11/11/21 | 14/02/22 | 30/05/22 | 09/08/22 | 10/11/22 | 09/02/23 | 29/05/23 | 09/08/23 | - | - | - | - |
More events
Past sector events for Natco Pharma Ltd.
| 2024-07-03 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected) |
| 2024-06-21 11:28 | DEVA HOLDING: Q1 2024 Earnings Release |
| 2024-06-13 17:21 | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
| 2024-06-11 01:30 | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
| 2024-06-07 06:33 | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
| 2024-06-07 05:17 | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
| 2024-05-30 08:08 | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-05-30 07:00 | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
| 2024-05-30 02:24 | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 08:00 | FDC LIMITED: Q4 2024 Earnings Release |
- Stock Market
- Equities
- NATCOPHARM Stock
- Stock
- Calendar Natco Pharma Ltd.
